Important Announcement

As a result of the US OHRP audit of the UBC Clinical Research Ethics Board (CREB) this past year; all UBC ethics boards have had to implement changes to stay in compliance with US regulations. All studies that need to comply with FDA requirements (indicated by an affirmative answer to question 7.12 of the RISe application form) such as US sponsored clinical trials and any study that is funded by a US government agency (NIH, DHHS) must be reviewed by the full board regardless of risk to the subjects. In addition, all related amendments and annual renewals must also be reviewed at the full board meeting.

Read the full memo. (7/12/10)

The Course in Human Research Participant Protection (CHRPP) is an interactive online course that equips participants with a deeper knowledge of the ethical treatment of human research participants. It also provides guidelines that are helpful in preparing applications for research ethics approval.

Tutorials are oriented towards research in the social sciences, health sciences and humanities and can be completed at your leisure. A certificate of completion is provided at the end of the course. Faculty, staff and students are encouraged to register for CHRPP at: http://www.chrpp.ca/UBC/login. A valid UBC or affiliated site email address (e.g. @cw.bc.ca, @bccancer.bc.ca, @providencehealthcare.bc.ca, @vch.ca) is required for registration.

For additional information concerning this educational opportunity, please contact Kirsten Bell, Research Ethics Analyst. (7/8/10)

Fraser Health REB now accepting UBC REB applications
UBC Principal Investigators affiliated with Fraser Health may now submit their UBC application form to Fraser Health for approval. This will enable researchers to use the same application form for both UBC and Fraser Health approvals. Read the letter outlining the new agreement. (3/31/10)

New toll free number for the UBC Research Subject Information Line
Please add this number to your standard wording when submitting amended consent forms. The new number is 1-877-822-8598. See Guidance Note 39.7.6 for further information. (2/16/10)

The new serious adverse events reporting method is now up-and-running on RISe. PLEASE DO NOT SEND any paper copies and ensure that you follow the Guidance notes for the reporting of SAE’s that are listed on our website. All SAE’s that do not meet the UBC C&W REB guidance notes will not be accepted. (11/16/09)

Changes to the RISe Application:
New Requirement to Complete Question 4.6
UBC has agreed to participate in a Canada-wide collaborative effort to expedite research studies that are time-sensitive in nature and related to public health emergencies such as pandemics (including H1N1).  In order to facilitate this process, researchers are now required to complete question 4.6 A of the research ethics application form, so that the Board and Research Ethics Administration can ensure that these studies are dealt with in accordance with the collaborative review process. This requires that all applicants must complete question 4.6A. If you do not complete this question, when the application is submitted you will be required to go back to complete the field. (9/10/09)